patched acts catalytically suppress activity smoothened 
mutations affecting transmembrane proteins patched ptc smoothened smo trigger ligand-independent activity hedgehog hh signalling pathway associated human tumours basal cell carcinoma bcc medulloblastoma- despite extensive genetic studies demonstrating importance receptor components embryonic patterning cancer mechanism ptc regulates smo understood report ptc smo significantly associated within hh-responsive cells furthermore show free ptc unbound hh acts sub-stoichiometrically suppress smo activity thus critical specifying level pathway activity patched twelve-transmembrane protein homology bacterial proton-driven transmembrane molecular transporters demonstrate function ptc impaired alterations residues conserved required function bacterial transporters results suggest ptc tumour suppressor functions normally transmembrane molecular transporter acts indirectly inhibit smo activity possibly changes distribution concentration small molecule 
